The immunological impact of orthomolecular medicine using bioactive compounds as key factors in endometriosis
Bioactive Compounds in Health and Disease · 2019
DOI: 10.31989/bchd.v2i1.555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioactive Compounds in Health and Disease, 2019. Verfasst von Alexandros Vlachos und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background: Endometriosis, an inflammatory, non-lethal, non-malignant disease, still has unjustified etiology. Among many, the theory dealing with this review claims that a suppressed or incompetent immune system that is totally unable to eradicate the non-hemopoietic mesenchymal endometriotic stem cell (MESC) escapes immune surveillance. As a result, there is migration and invasion of the aforementioned cell to ectopic tissues causing the disease. Keywords: bioactive compounds, functional foods, endometriosis, orthomolecular medicine, mesenchymal endometriotic stem cell (MESC), immune system
Zitieren
APA
Vlachos, A., & Vassiliadis, S. (2019). The immunological impact of orthomolecular medicine using bioactive compounds as key factors in endometriosis. Bioactive Compounds in Health and Disease. https://doi.org/10.31989/bchd.v2i1.555
Vancouver
Vlachos A, Vassiliadis S. The immunological impact of orthomolecular medicine using bioactive compounds as key factors in endometriosis. Bioactive Compounds in Health and Disease. 2019. doi:10.31989/bchd.v2i1.555
BibTeX
@article{Vlachos2019,
author = {Vlachos, Alexandros and Vassiliadis, Simon},
title = {The immunological impact of orthomolecular medicine using bioactive compounds as key factors in endometriosis},
journal = {Bioactive Compounds in Health and Disease},
year = {2019},
doi = {10.31989/bchd.v2i1.555}
}
EUVIMED